Drugs / Baofukang Suppository
last change May 2020 re-read 3 minutes ago

Baofukang Suppository

Developed for
vaginitis
Investigated by
Peking University Shenzhen Hospital

Trials 1

2021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04574089 May 2020 → Dec 2026 expected vaginitis Peking University Shenzhen Hospital Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Baofukang Suppository ClinicalTrials.gov intervention name — accepted as the source's own label NCT04574089 ↗